BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 590854)

  • 1. Carcinoembryonic antigen in gynecologic patients. I. Correlation of plasma levels and tissue localization.
    Puri S; Mesa-Tejada R; Husami N; Bennett S; Richart RM; Fenogolio CM
    Gynecol Oncol; 1977 Dec; 5(4):331-7. PubMed ID: 590854
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM; Crum CP; Pascal RR; Richart RM
    Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A critical study on the differentiation of the acceleration of the erythrocyte sedimentation rate due to tumorous and inflammatory processes in diseases of the female genitalia].
    Schander K
    Z Geburtshilfe Gynakol; 1969; 170(1):73-7. PubMed ID: 5794762
    [No Abstract]   [Full Text] [Related]  

  • 4. The circulating alpha subunit of human chorionic gonadotrophin in gynaecologic tumours.
    Rutanen EM
    Int J Cancer; 1978 Oct; 22(4):413-21. PubMed ID: 700896
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
    Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K; Breborowicz J
    Ginekol Pol; 1979 Dec; 50(12):1029-36. PubMed ID: 94024
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum copper alterations in genital cancer.
    O'Leary JA; Feldman M
    Surg Forum; 1970; 21():411-2. PubMed ID: 5514783
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasma fibrinogen in female patients with genital cancer and its early stage].
    Lober R; Krantz S; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):71-81. PubMed ID: 2581873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen degradation products in gynecologic neoplasms].
    Tatra G; Breitenecker G; Karsai I
    Fortschr Med; 1976 May; 94(13):752-4. PubMed ID: 955534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients.
    Tredese F; Maggino T; Salvagno L; Marchesoni D; Chizzolini M; Pattaro RF
    Eur J Gynaecol Oncol; 1985; 6(2):136-8. PubMed ID: 4029198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary evaluation of the usefulness of determination of blood serum fucose and sialic acid level in women with genital tumors].
    Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K
    Ginekol Pol; 1979 Nov; 50(11):957-63. PubMed ID: 544355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical findings in malignant neoplasms of the female genital organs].
    Koshkina SI; Makarov KS; Shiferson RG; Pchelkin EI; Zelentsovskaia GP
    Vopr Onkol; 1967; 13(1):107. PubMed ID: 4176512
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.
    Rutanen EM; Lindgren J; Sipponen P; Stenman UP; Saksela E; Seppäla M
    Cancer; 1978 Aug; 42(2):581-90. PubMed ID: 354771
    [No Abstract]   [Full Text] [Related]  

  • 15. Seromucoid in serum in benign and malignant gynaecological disorders.
    Randle GH; Good W; Cumberbatch KN
    J Obstet Gynaecol Br Commonw; 1974 Jun; 81(6):479-82. PubMed ID: 4407083
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of the serum concentration of pregnancy associated alpha 2 glycoprotein (alpha 2-PAG) in gynecologic carcinomas (author's transl)].
    Tatra G
    Strahlentherapie; 1981 Jul; 157(7):464-7. PubMed ID: 7268817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vitamins A and E and carotene in patients with gynecologic cancer.
    Heinonen PK; Kuoppala T; Koskinen T; Punnonen R
    Arch Gynecol Obstet; 1987; 241(3):151-6. PubMed ID: 3435184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy associated alpha2-glycoprotein (alpha2-PAG) in the serum of patients with gynecologic carcinomas].
    Bauer HW; Kraus H
    Onkologie; 1978 Oct; 1(5):180-3. PubMed ID: 83557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of T.P.A. (tissue polypeptide antigen) in gynecological malignancies.
    Restaino A; Fanizza G; Battarino O
    Eur J Gynaecol Oncol; 1986; 7(3):183-5. PubMed ID: 3780759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum levels of a immunosuppressive acidic protein in patients with gynecological cancer (author's transl)].
    Suzuki H; Miyoshi T; Sasaki H; Yoshida T
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):513-8. PubMed ID: 6785990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.